Providing new technologies for vaccine development

Providing new technologies for vaccine development
Credit: Design_Cells/Shutterstock

Vaccines, which help the body recognize infectious microorganisms and stage a stronger and faster response, are made up of proteins that are specific to each type of microorganism. In the case of a virus, viral proteins—or antigens—can sometimes be attached to a protein scaffold to help mimic the shape of the virus and elicit a stronger immune response. Using scaffolds to approximate the natural configuration of the antigen is an emerging approach to vaccine design.

A team of scientists led by David Baker at the University of Washington developed a method to design artificial proteins to serve as a framework for the viral antigens. Their study was published recently in the journal eLife. Berkeley Lab scientists collected data at the Advanced Light Source to visualize the and determine the dynamics of the designed scaffolds.

"When bound, the scaffolds assume predicted geometries, which more closely approximate the virus shape and thereby maximize the immune response," said Banu Sankaran, a research scientist in the Molecular Biophysics and Integrated Bioimaging (MBIB) Division. "It was exciting to collaborate on this method to predictably design frameworks, which could lead to more effective vaccines, especially for viruses that we don't have a scaffold for."


Explore further

Engineers use 'DNA origami' to identify vaccine design rules

More information: George Ueda et al. Tailored design of protein nanoparticle scaffolds for multivalent presentation of viral glycoprotein antigens, eLife (2020). DOI: 10.7554/eLife.57659
Journal information: eLife

Citation: Providing new technologies for vaccine development (2020, October 1) retrieved 25 November 2020 from https://medicalxpress.com/news/2020-10-technologies-vaccine.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
1 shares

Feedback to editors

User comments